Trending
News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Rottapharm | Madaus Acquires the Zyma® Brands; Plexus Ventures Facilitated the Deal
"Los Angeles, California -- Plexus Ventures is pleased to announce the successful completion of a recent divestment project. Plexus provided professional services to the seller in their divestment of the Zyma® Brands to Rottapharm | Madaus in 19 countries including...
Novartis Divests Optalidon to Omega Pharma
London, United Kingdom — Plexus Ventures is pleased to announce the conclusion of a successful divestment assignment for Novartis Consumer Health (Switzerland), for which Plexus Ventures acted as exclusive external advisor. Novartis recently sold the rights to...
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.